| Anaplastic thyroid carcinoma: an update A Jannin, A Escande, A Al Ghuzlan, P Blanchard, D Hartl, B Chevalier, ... Cancers 14 (4), 1061, 2022 | 68 | 2022 |
| Metformin:(future) best friend of the radiation oncologist? B Chevalier, D Pasquier, EF Lartigau, C Chargari, A Schernberg, ... Radiotherapy and Oncology 151, 95-105, 2020 | 22 | 2020 |
| Bilateral adrenal hyperplasia: pathogenesis and treatment B Chevalier, MC Vantyghem, S Espiard Biomedicines 9 (10), 1397, 2021 | 20 | 2021 |
| Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network H Mosbah, MC Vantyghem, E Nobécourt, F Andreelli, F Archambeaud, ... Diabetes, Obesity and Metabolism 24 (8), 1565-1577, 2022 | 17 | 2022 |
| Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival A Jannin, L Lamartina, C Moutarde, M Djennaoui, G Lion, B Chevalier, ... European journal of nuclear medicine and molecular imaging 49 (7), 2401-2413, 2022 | 17 | 2022 |
| Impact of lymph node dissection on postoperative complications of total thyroidectomy in patients with thyroid carcinoma G Baud, A Jannin, C Marciniak, B Chevalier, C Do Cao, E Leteurtre, ... Cancers 14 (21), 5462, 2022 | 16 | 2022 |
| Oral-tolerization prevents immune responses and improves transgene persistence following gene transfer mediated by adeno-associated viral vector R Hardet, B Chevalier, L Dupaty, Y Naïmi, G Riou, L Drouot, L Jean, ... Molecular Therapy 24 (1), 87-95, 2016 | 16 | 2016 |
| Multiple symmetric and multiple familial lipomatosis M Lemaitre, B Chevalier, A Jannin, J Bourry, S Espiard, MC Vantyghem La Presse Médicale 50 (3), 104077, 2021 | 14 | 2021 |
| Multiple endocrine neoplasia type 4: novel CDNK1B variant and immune anomalies B Chevalier, MF Odou, J Demonchy, C Cardot-Bauters, MC Vantyghem Annales d'Endocrinologie 81 (2-3), 124-125, 2020 | 14 | 2020 |
| Rare forms of lipomatosis: Dercum’s disease and Roch-Leri Mesosomatous lipomatosis M Lemaitre, S Aubert, B Chevalier, A Jannin, J Bourry, G Prévost, ... Journal of Clinical Medicine 10 (6), 1292, 2021 | 11 | 2021 |
| Phakomatoses and endocrine gland tumors: noteworthy and (not so) rare associations B Chevalier, H Dupuis, A Jannin, M Lemaitre, C Do Cao, ... Frontiers in Endocrinology 12, 678869, 2021 | 6 | 2021 |
| The heart, an endocrine gland: natriuretic peptides M Lemaitre, A Jannin, B Chevalier, MC Vantyghem Annales d'endocrinologie 83 (1), 59-62, 2022 | 5 | 2022 |
| Metreleptin treatment of non-HIV lipodystrophy syndromes B Chevalier, M Lemaitre, L Leguier, K Le Mapihan, C Douillard, A Jannin, ... La Presse Médicale 50 (3), 104070, 2021 | 5 | 2021 |
| Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments B Chevalier, A Jannin, S Espiard, E Merlen, A Beron, G Lion, ... La Presse Médicale 51 (2), 104144, 2022 | 4 | 2022 |
| Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis M Lemaitre, B Chevalier, A Jannin, K Le Mapihan, S Boury, G Lion, ... Orphanet Journal of Rare Diseases 16 (1), 290, 2021 | 4 | 2021 |
| MEN1 and the brain: don't just look only at the pituitary gland. A case report of anaplastic pleomorphic xanthoastrocytoma in a MEN1 patient, and systematic review A Jannin, L Coppin, B Chevalier, CA Maurage, MF Odou, CC Bauters Annales d'endocrinologie 84 (4), 424-426, 2023 | 2 | 2023 |
| Complete pathological response following chemotherapy and radiotherapy in two cases of advanced anaplastic thyroid carcinoma B Chevalier, O Karleskind, A Jannin, O Farchi, C Vermaut, A Escande, ... European Thyroid Journal 12 (1), 2023 | 2 | 2023 |
| Beyond MEN1, when to think about MEN4? Retrospective study on 5600 patients in the French population and literature review B Chevalier, L Coppin, P Romanet, T Cuny, JC Maïza, J Abeillon, ... The Journal of Clinical Endocrinology & Metabolism 109 (7), e1482-e1493, 2024 | 1 | 2024 |
| Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1 H Dupuis, B Chevalier, C Cardot-Bauters, A Jannin, C Do Cao, ... Journal of the Endocrine Society 7 (8), bvad083, 2023 | 1 | 2023 |
| Metabolism of pancreatic neuroendocrine tumors: what can omics tell us? A Jannin, AF Dessein, C Do Cao, MC Vantyghem, B Chevalier, ... Frontiers in Endocrinology 14, 1248575, 2023 | | 2023 |
